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Ureteral stenosis is a rare manifestation of granulomatosis with polyangiitis (formerly known as Wegener’s granulomatosis). We
report the case of a 76-year-old woman with progressive renal failure in which bilateral hydronephrosis due to ureteral stenosis
was the first manifestation of the disease. Our patient also had renal involvement with pauci-immune crescentic glomerulo-
nephritis associated with high titers of anti-proteinase 3 c-ANCAs, but no involvement of the upper or lower respiratory tract.*e
hydronephrosis and renal function rapidly improved under immunosuppressive therapy with high-dose corticosteroids and
intravenous pulse cyclophosphamide. We reviewed the literature and found only ten other reported cases of granulomatosis with
polyangiitis/Wegener’s granulomatosis and intrinsic ureteral stenosis: in two cases, the presenting clinical manifestation was
unilateral hydronephrosis and in only two others was the hydronephrosis bilateral, but this complication developed during a
relapse of the disease. *is case emphasizes the importance of including ANCA-related vasculitis in the differential diagnosis of
unusual cases of unilateral or bilateral ureteral stenosis.
1. Introduction
Granulomatosis with polyangiitis (GPA) (formerly known as
Wegener’s granulomatosis) is a necrotizing vasculitis of the
small to medium vessels, according to the revised Interna-
tional Chapel Hill Consensus Conference Nomenclature of
Vasculitides [1]. Its classic triad consists of necrotizing
granulomatous vasculitis of the upper and lower respiratory
tract in association with pauci-immune crescentic glomeru-
lonephritis [2]. It is often associated with antineutrophilic
cytoplasmic antibodies (ANCA) against proteinase 3 (anti-
PR3), but occasionally also against myeloperoxidase (anti-
MPO) [2]. GPA is an uncommon disease, with an annual
incidence of about 10 cases per million inhabitants, a prev-
alence of 22–157 cases per million [3] and a peak incidence in
the fourth and fifth decades of life [4]. Men and women are
affected at a similar frequency. GPA was a fatal disease before
the introduction of effective immunosuppressive treatments.
*e use of high-dose corticosteroids associated with cyclo-
phosphamide has markedly improved survival as well as renal
survival of patients with ANCA-associated vasculitis [3].
GPA can affect all organs of the body. Although rare,
urogenital manifestation can occur during the course of the
disease and may be asymptomatic [5]. Granulomatous in-
flammation of the prostate, bladder, penis, testes, seminal
vesicles, ureters, urethra and epididymis have already been
reported.
We are reporting on a case in which bilateral hydro-
nephrosis due to bilateral ureteral stenosis was the first
clinical manifestation of GPA. Ureteral stenosis is a rare
complication of GPA: only 11 cases (including ours) have
been reported in the literature to date and, to our knowledge,
our case is the first one in which bilateral hydronephrosis
was the presenting manifestation of the disease.
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2. Case Report
A 76-year-old woman was transferred to our hospital after a
6-month history of progressive renal failure with bilateral
hydronephrosis of unclear origin and normal cystoscopy.
At admission the patient complained of fatigue, bilateral leg
oedema and a 10kg weight loss.*e patient denied any episode
of macroscopic hematuria. Clinical examination found a pa-
tient in poor general condition with bilateral pitting edema of
the legs. Temperature was 36.5°C, blood pressure 135/
70mmHg. *e laboratory findings were as follows: serum
creatinine was 601μmol/l, urea 39.5mmol/l, total protein
57.5 g/l, serum albumin 28 g/l, sodium 143mmol/l, potassium
4.8mmol/l. *e sedimentation rate was 81mm/h, C-reactive
protein (CRP) 33mg/l, hemoglobin 107 g/l, leukocyte count
7.2G/l and platelets 333G/l. Urinalysis showed microscopic
hematuria with mild leukocyturia. Urine culture was sterile.
Creatinine clearance was 4ml/min. Proteinuria was present at
1.9 g/24h, without paraproteins.
A native abdominal CT scan was performed showing bi-
lateral hydro-uretero-nephrosis with massive dilatation of the
upper ureters and of the renal pelvis (Figure 1(a)).*e CTscan
showed no signs of an obstructive abdomino-pelvic mass, of
retroperitoneal fibrosis, urolithiasis or sloughed papillary ne-
crosis. Bilateral ureteral catheterization using double J catheters
was performed and the retrograde pyelography revealed that
the bilateral hydronephrosis was due to a complete right
ureteral stenosis and a partial stenosis on the left side (Figure 2).
As bilateral malignancy was considered in the differential
diagnosis a small periprocedural ureteral biopsywas performed
showing only nonspecific inflammation without tumoral cells.
In the following days, despite an improvement of di-
uresis (≈2000ml/day) with double J catheters, no im-
provement of renal function occurred. *e diagnostic
workup was therefore completed with immunological tests
showing high c-ANCA titers (1 :1280) with anti-PR3 posi-
tivity. *ereafter, a kidney biopsy detected pauci-immune
crescentic glomerulonephritis (Figure 3).*e ENTexam and
a native pulmonary CT scan were normal.
Treatment with pulse methylprednisolone (4×1 gram)
followed by oral prednisone in combination with monthly
intravenous pulse cyclophosphamide (3× 500mg) was
started. Renal function progressively improved in the fol-
lowing weeks and the creatinine stabilized at 140 μmol/l after
3months, with negative c-ANCA. At the same time repeated
ultrasounds showed a progressive regression of the hydro-
uretero-nephrosis and the double J catheters were with-
drawn. A follow-up CTscan at 3 months showed a complete
regression of the hydronephrosis on the left side and a partial
regression on the right side (Figure 1(b)). Of note this
second CT scan, as the first one, showed no evidence of an
obstructive abdomino-pelvic mass, of retroperitoneal fi-
brosis, urolithiasis or papillary necrosis.
3. Discussion
In adults, the most frequent causes of bilateral ureteral
obstruction are retroperitoneal or pelvic neoplasms, calculi,
or retroperitoneal fibrosis. However, the differential
diagnosis also includes other rare etiologies. Table 1 sum-
marizes the causes of bilateral, or potentially bilateral,
ureteral obstruction according to the mechanism of ob-
struction and shows that different inflammatory or systemic
diseases, including small and medium vessel vasculitis, can
cause bilateral hydro-uretero-nephrosis. As we will discuss
further below, sometimes, unilateral or bilateral ureteral
stenosis with hydronephrosis may be due to ANCA-asso-
ciated vasculitis. To our knowledge, we are reporting on the
first patient with bilateral hydronephrosis as the presenting
manifestation of ANCA-associated vasculitis.
Urogenital involvement is rare in GPA. Large series of
GPA patients have reported between 1% and 10% of cases
with urogenital involvement [6, 24]. Cases of asymptomatic
urogenital involvement have also been reported in autopsy
studies of patients with GPA, and urological manifestation
may be underestimated because complete urological in-
vestigations are not routinely performed [5]. *e main lo-
cations of the urogenital manifestations of GPA are
summarized in Table 2. Prostatitis is the most common,
followed by bladder involvement, orchitis, and penile ul-
cerations [5]. When urological involvement is present, it is
usually observed as part of a generalized systemic disease
associated with upper respiratory involvement in 90–100%
of the cases, pulmonary lesions in 80%, and glomerulone-
phritis in 45–60% [5]. Isolated urological manifestations can
precede GPA diagnosis in 12–18% of the cases having
urological involvement [6, 24]. Intrinsic ureteral stenosis is a
rare manifestation of GPA as only 11 cases (including ours)
have been reported in the literature to date [6, 24–30].
Huong et al. [6] and Kamar et al. [27] each described two
cases. One case was reported twice by the same author [6,
31]. Two other cases were published twice [26, 29, 32, 33] and
another case three times [25, 34, 35]. It should be noted that
cases of patients with GPA in which hydronephrosis was due
to extrinsic ureteral obstruction caused by retroperitoneal
inflammation, pseudotumors, or vascular compression as
well as prostatic obstruction as a consequence of GPA-re-
lated inflammation have also been reported [36–44].
Table 3 summarizes the main clinical features of the 11
cases of ureteral stenosis reported in the literature. In most
cases (8/11� 73%), the ureteral involvement occurred
during a relapse of GPA and in only two cases was the
involvement bilateral [6, 26]. In the two remaining cases, the
ureteral stenosis was, as in our patient, the initial mani-
festation of GPA, but in these two patients, the hydro-
nephrosis was unilateral [27, 30]. Davenport et al. briefly
described a case of initial manifestation of GPA with bi-
lateral ureteral obstruction, but this was due to necrotic
debris in the bladder and in the two ureters [43]. Inter-
estingly, a case of ureteral stenosis has also been reported in a
kidney transplant due to the recurrence of GPA after
transplantation [28].
In 6 of these 11 cases, open ureteral surgery was per-
formed as part of the diagnostic and/or therapeutic workup
and granulomatous/vasculitic inflammation was found in all
[24, 27–30]. In the other four cases that underwent only an
endoscopic workup, no ureteral biopsy was performed [6,
25, 26]. Hence, our case is in fact the only one where a small
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endoscopic biopsy was performed in order to rule out
malignancy. *is biopsy showed only nonspecific inflam-
mation, and we consider that our biopsy was too small and
superficial to allow the detection of a granulomatous or
vasculitic inflammation. However, one may question if the
bilateral ureteric stenosis in our patient may eventually be
unrelated to the ANCA-associated vasculitis. In this respect,
(a) (b)
Figure 1: Native CTscan (a) at admission showing massive bilateral hydronephrosis and (b) at 3 months showing a complete regression of
the hydronephrosis on the left side and a partial regression on the right side.
Figure 2: Retrograde pyelography showing bilateral hydro-ure-
tero-nephrosis with a complete ureteral stenosis on the right and a
partial ureteral stenosis on the left.
Figure 3: Renal biopsy showing extracapillary crescentic glo-
merulonephritis involving almost all glomeruli (HE, 100x).
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Miscellaneous Pregnancy, slowed peristalsis,obstructed stent, postoperative
∗Adapted from references [6–23]. ∗∗Some can cause either intrinsic or
extrinsic obstruction. RA� rheumatoid arthritis.
Table 2: Relative frequency of the different urogenital manifes-
tations of granulomatosis with polyangiitis.
Site Clinical manifestations Frequency
Prostate Prostatitis, urinary retention,asymptomatic +++++
Bladder Cystitis, pseudotumor ++++
Penis Ulcerations +++
Testicles Orchitis +++
Kidneys Pseudotumors, asymptomatic +++
Urethra Urethritis ++
Ureter Stenosis, hydronephrosis ++
Epididymis Epididymitis +
Data adapted from Alba et al. [5].
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we consider that the accurate initial diagnostic workup, the
follow-up exams performed at 3 months, and the favourable
response with the regression of the hydro-uretero-nephrosis
under immunosuppressive therapy allow to reasonably rule
out the alternative diagnosis listed in Table 1.
Concerning ANCAs, ANCA determinations were not
performed on the oldest cases reported in the literature as this
diagnostic test was not yet available at the time. Except for the
two cases reported by Kamar et al., ANCA was positive in all
other cases, with anti-PR3 positivity in three patients and
anti-MPO positivity in one. *e two ANCA-negative cases
reported by Kamar et al. are unique since these two patients
had isolated 2 and 3 cm long unilateral ureteral stenoses with
granulomatous inflammation at surgical resection as the sole
manifestation of the disease [27].
*e treatment of GPA with a combination of gluco-
corticoids and immunosuppressants, mainly cyclophos-
phamide, has been well established. All but three of the
reported patients received this treatment and responded well
to it (Table 3). To the best of our knowledge, the recurrence
of ureteral stenosis upon medical treatment has never been
reported. Endoscopic placement of double J catheters was
performed in our case, as well as in five others [6, 24, 26],
followed by open surgery in two cases [27]. Open surgery
was initially performed in four cases [28–30, 35]. *e last
case underwent no urological therapy as the patient
Table 3: Summary and characteristics of the reported cases of ureteral stenosis in GPA.
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Moderate dilatation












Positive NA Ureteralresection PRED+CYC+AZA
Remission
at 15 yr
6 1995 55 M Relapse Right-sided ureteralstenosis Positive NA None PRED
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at 5 yr
27 2003 21 M Relapse
Isolated right
hydronephrosis with
a 2 cm-long stenosis
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∗Cases reported two or three times. F: female, M: male, NA: not available, PRED: prednisone, CYC: cyclophosphamide, MTX: methotrexate, AZA:
azathioprine, and yr: year.
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responded rapidly to immunosuppression [6]. In general,
surgical repair of the ureters is unnecessary because uro-
logical symptoms improve quickly on medical treatment.
Consequently, all authors advocate that surgery should only
be considered in patients who do not rapidly and effectively
respond to the combination of corticoids and
immunosuppressants.
In summary, the present review indicates that unilateral
or bilateral ureteral stenosis can be the first clinical mani-
festation of GPA or may occur during a relapse of the
disease. Since the clinical presentation may mimic cancer,
the right diagnosis can avoid unnecessarily invasive pro-
cedures. *erefore, ANCA-related vasculitis should be
considered in the differential diagnosis of unusual cases of
unilateral or bilateral ureteral stenosis and ANCA testing
should be performed in patients in whom a diagnosis is not
readily apparent. *e data from the reviewed literature
suggest that ureteral stenosis responds well and rapidly to
glucocorticoids and immunosuppressants.
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